Current medical science · 2025
Expert Consensus on Clinical Application of Implantable Biventricular Assist Devices.
Consensus StatementСтатьяКлинические рекомендацииНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dong Nian-Guo, D'Alessandro David, Karimov Jamshid, Wang I-Wen, Chen Liang-Wan, Xiao Ying-Bin, Wang Chun-Sheng, Zhao Qiang, Shi Jia-Wei, Yu Shun-Zhou, Zhou Cheng, Leprince Pascal, Ono Minoru, Schmitto Jan, Gong Ming, Shao Yong-Feng, Wang Xian-Qiang, Hao Xing, Hou Xiao-Tong, Li Xin, Wang Wei, Wu Ting, Zhang Hai-Tao, Zhou Cheng-Bin, Li Ping, Wang Yin, Wang Yi-Xuan, Zhang Jing, Extracorporeal Life Support Professional Committee, Chinese Medical Doctor Association
Аннотация
While biventricular assist devices (BiVADs) remain underutilized in Western countries for biventricular heart failure (BHF), their application is expanding in China. This consensus synthesizes international guidelines, medical evidence, and Chinese clinical expertise to establish standardized protocols for BiVAD management. Key recommendations include: (1) Preoperative right heart catheterization and echocardiography for central venous pressure (CVP): pulmonary capillary wedge pressure (PCWP) ratio and pulmonary artery pulsatility index (PAPi) assessment (Class I); (2) BiVAD indication in refractory BHF or high-risk right heart failure post-left ventricular assist device (LVAD) implantation (Class IIa); (3) Right atrial implantation as the preferred surgical approach (Class IIa); (4) Warfarin-based anticoagulation (INR 2.0-2.5) with aspirin, avoiding direct oral anticoagulants (DOACs) (Class III). The guidance addresses critical gaps in patient selection, pump speed titration, and complication management, positioning integrated BiVAD systems as a promising solution for complex BHF.